---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-038060"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2024-09-25T23:59:59+00:00"
generated_at: "2026-05-31T01:58:19.227630+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# QHSLab secures $297K grant from global consumer health firm for allergic rhinitis digital study

## Summary
- QHSLab received $297,360 grant from a Global Leader in Consumer Health to advance digital medicine for allergic rhinitis.
- Study registered as NCT06603935 on ClinicalTrials.gov; titled 'Harnessing Digital Medicine Tools...'
- Research will evaluate QHSLab's AME and ARIS digital tools for primary care allergy management.
- Principal Investigator: Marcos Sanchez-Gonzalez, MD, PhD; study aims to improve patient outcomes and reduce costs.
- Grant reflects shared commitment to digital health innovation and evidence-based self-care for patients.

## SEC filing metadata
- accession: 0001493152-24-038060
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2024-09-25T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315224038060/0001493152-24-038060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315224038060/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-038060
- JSON: https://secwatch.observer/filing/0001493152-24-038060.json
- Plain text: https://secwatch.observer/filing/0001493152-24-038060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.